Registered number: 10746238

Pharmekon Ltd
Unaudited Financial Statements
for the year ended 30 April 2023

# Statement of Financial Position

as at 30 April 2023

|  | 2023 | 2022
£ | £
£ | £
Called up share capital not paid |  |
| -
| -
Fixed assets |  |
| 699
| 1,151
Current assets |  |
172,295 |
172,821 |
Prepayments and accrued income |  |
- |
- |
Creditors: amounts falling due within one year |  |
( 16,317 ) |
( 255 ) |
Net current assets (liabilities) |  |
| 155,978
| 172,566
Total assets less current liabilities |  |
| 156,677
| 173,717
Creditors: amounts falling due after more than one year |  |
| -
| -
Provisions for liabilities |  |
| -
| -
Accruals and deferred income |  |
| -
| ( 675 )
Net assets |  |
| 156,677
| 173,042
Capital and reserves |  |
| 156,677
| 173,042

xbrli:pure 10746238 2022-05-01 2023-04-30 10746238 2021-05-01 2022-04-30 10746238 2023-04-30 10746238 2022-04-30 10746238 2022-05-01 10746238 uk-frs102:WithinOneYear 2023-04-30 10746238 uk-frs102:AfterOneYear 2023-04-30 10746238 uk-frs102:WithinOneYear 2022-04-30 10746238 uk-frs102:AfterOneYear 2022-04-30 10746238 uk-bus:AuditExempt-NoAccountantsReport 2022-05-01 2023-04-30 10746238 uk-bus:AbbreviatedAccounts 2022-05-01 2023-04-30 10746238 uk-bus:Director1 1 2022-05-01 2023-04-30 10746238 uk-bus:Director1 2022-05-01 2023-04-30 10746238 uk-bus:Director1 1 2022-05-01 10746238 uk-bus:Director1 1 2023-04-30 10746238 uk-bus:Micro-entities 2022-05-01 2023-04-30 10746238 uk-bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 iso4217:GBP 10746238 countries:EnglandWales 2022-05-01 2023-04-30 10746238 uk-bus:RegisteredOffice 2022-05-01 2023-04-30

Footnotes to the Statement of Financial Position

Sophia Marsh

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Sophia Marsh

Included in creditors is an amount due to be paid by the company to one of its directors. The amount is an advance made to the company of £5 by Sophia Marsh, a director of the company, on 01/05/2022.

During the accounting year the maximum amount repayable to Sophia Marsh was £5,000

The following conditions are attached to amount payable to Sophia Marsh:

- There is no interest due to be paid on any outstanding amount
- No fixed date has been set for the amount to be repaid by the company.

Opening balance 01/05/2022 | Additional advance | Amount repaid | Amount written off | Amounts waived | Interest payable | Closing balance 30/04/2023
--- | --- | --- | --- | --- | --- | ---
£ | £ | £ | £ | £ | £ | £
0 | ( 5,002 ) ( 5,002 ) | 5,007 5,007 | 0 | 0 | 0 | 5

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 30/04/2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 10746238

c) The company is a private company and is limited by shares

d) The companies registered office address is W8a Knoll Business Centre 325-327 Old Shoreham Road, Hove, BN3 7GS, England

Approved by the board of directors and signed on behalf of the board,

Pharmekon Ltd
Director Sophia Marsh
Date of approval: 04/10/2023
The company was trading for the entire period 2022-05-01 2023-04-30 2023-04-30 Pharmaceutical industry 2023-10-04 2023-10-04